Factor Xa inhibitors (DOACs): Pharmacology Made Easy & Relevant

Factor Xa inhibitors (DOACs) made easy—fast, clear, and clinically relevant. In this lecture from This is Why, Dr. Busti will break down direct oral anticoagulants (DOACs) and how Factor Xa inhibitors work, with relevance.

You’ll learn how to:
- What Factor Xa inhibitors do (mechanism of action)
- Key drugs: Apixaban (Eliquis), Rivaroxaban (Xarelto), Edoxaban (Savaysa)
- Common indications: Afib stroke prevention, DVT/PE treatment
- Major adverse effects and safety: bleeding risk, interactions, and monitoring pearls
- Reversal overview: What to know + when it matters

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/doac-factor-xa-inhibitors-anticoagulants-pharmacology-review

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#FactorXaInhibitors #DOACs #Anticoagulation #Apixaban #drbusti

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.